Results 11 to 20 of about 10,975 (245)

Delayed Diagnosis of Atypical Presentation of Myasthenia Gravis [PDF]

European Journal of Case Reports in Internal Medicine, 2017
Myasthenia gravis is an autoimmune disorder affecting the neuromuscular junction, resulting in muscle fatiguability and weakness. The pathological characteristics of the disorder include ocular weakness resulting in diplopia and/or ptosis.
Moneeb Sefeldawla Mustafa, Megan Marshal, Emer Ahern, Paul Crowley   +3 more
doaj   +4 more sources

Ocular myasthenia gravis: A review

Indian Journal of Ophthalmology, 2014
Myasthenia gravis (MG) is a disease that affects the neuro-muscular junction resulting in classical symptoms of variable muscle weakness and fatigability. It is called the great masquerader owing to its varied clinical presentations.
Akshay Gopinathan Nair, Preeti Patil-Chhablani, Devendra V Venkatramani, Rashmin Anilkumar Gandhi   +3 more
doaj   +3 more sources

Late-Onset Ocular Myasthenia Gravis-Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Report. [PDF]

Biologics
Qaqish A, Al Anber A, Abdelhafez G.
europepmc   +3 more sources

Cavernous Sinus Dural Arteriovenous Fistula Initially Misdiagnosed As Ocular Myasthenia Gravis: A Case Report. [PDF]

Cureus
Yamamoto S, Watanabe G, Akao G, Sato K, Suzuki Y.   +4 more
europepmc   +3 more sources

Clinical characteristics and outcome predictors of a Chinese childhood-onset myasthenia gravis cohort

Frontiers in Pediatrics, 2022
Myasthenia gravis is an organ-specific autoimmune disease. Currently there is no universal guidelines for childhood-onset myasthenia gravis, therefore, treatment strategies are usually based on the guidelines from adult myasthenia gravis patients.
Lifen Yang, Yulin Tang, Fang He, Ciliu Zhang, Miriam Kessi, Jing Peng, Fei Yin   +6 more
doaj   +1 more source

Refractory generalized myasthenia gravis with myasthenic incomplete ophthalmoplegia successfully treated with eculizumab

American Journal of Ophthalmology Case Reports, 2023
Purpose: This is a case of myasthenic incomplete ophthalmoplegia mimicking a partial cranial nerve 3 palsy both subjectively and objectively improving after treatment with eculizumab.
Sara L. Weidmayer, Gary Gallagher
doaj   +1 more source

OMGMed: Advanced System for Ocular Myasthenia Gravis Diagnosis via Eye Image Segmentation [PDF]

Bioengineering (Basel)
Li J, Zhu C, Zhao M, Xu X, Zhao L, Cheng W, Liu S, Zou J, Yang J, Yin J.   +9 more
europepmc   +3 more sources

Avelumab-Induced Ocular Myasthenia Gravis: A Case Report. [PDF]

Cureus
Khaokong R, Ling YT, Mugunthan T.
europepmc   +3 more sources

Concentric Needle Jitter in 97 Myasthenia Gravis Patients

Frontiers in Neurology, 2020
Objectives: To estimate the jitter parameters (single-fiber electromyography) in myasthenia gravis patients mostly by electrical activation in Frontalis, Orbicularis Oculi, and Extensor Digitorum muscles using a concentric needle electrode.Methods ...
João Aris Kouyoumdjian, Gabriel Pina Paiva, Erik Stålberg   +2 more
doaj   +1 more source

Tolosa-Hunt syndrome with general myasthenia gravis involvement [PDF]

Journal of Integrative Neuroscience, 2020
Tolosa-Hunt syndrome is an uncommon disease that exhibits unilateral periorbital pain or headache, accompanied by cranial nerve palsies. Myasthenia gravis is an acquired immune system disease involving the neuromuscular junction.
Lu Li, Zhe Wang, Ming-Ou Lu
doaj   +1 more source